Eduardo J.Banegas Deras

🔰Lipid Lowering Therapies in Chronic Kidney Disease: A call to action. 1️⃣Chronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular events. 2️⃣ Lipid-lowering therapies (LLT) remain underused in CKD patients despite Guideline recommmendations 3️⃣ Patients with advanced stages of CKD are frequently excluded from clinical trials. 4️⃣ Although novel LLT options demonstrate potential, the evidence supporting their use in CKD populations remains limited. 5️⃣ A concerted effort from clinicians, regulators, and industry stakeholders is essential to address these gaps. doi.org/10.1016/j.athe… @JonathanNefro @elbaonelida @PerlaZambrano @PepaSolerR @SLANH_ @SENefrologia @ASNKidney @jorgericof @anymzcs @drshafikuchay @maciejbanach @MeralKayikcoglu

Top3 heart failure trials in October 2025 🥇CCS/CHFS 2025 Guideline update for pharmacologic management of HF with LVEF > 40% @CanHFSociety 🥈The chloride paradigm shift in HF @escardio 🥉Consensus statement. HF pharmacotherapy for patients with HFrEF➕ AF @ESC_Journals

🚨 New in European Journal of Heart Failure: “The chloride paradigm shift in heart failure — from neglected ion to keystone of precision diuretic therapy.” 👇 Why #chloride may reshape how we manage congestion in #HeartFailure. 📄 onlinelibrary.wiley.com/doi/10.1002/ej… #CardioRenal #HF #AKI #Nephrology @ESC_Journals @ERAkidney @SENefrologia @EmiliSanAlv @PepaSolerR @JonathanNefro @rdelaespriella @JaimeMazonRuiz @rdelaespriella @MartaCoboMarcos @secardiologia @CardioRenalSEC @hgermanstrias @nfrgermanstrias @AmirKazory

🆕”The chloride paradigm shift in HF: From neglected ion to keystone of precisión diurética therapy” ✅⬇️Cl-: ⬇️Respuesta diurética, mantiene💦,⬆️⚰️y🏥 ✅⬇️Cl-: 🎯💊, diuréticos ahorradores Cl-, SSH, Repleccion Cl- con 🧂sin NaCl @JaimeMazonRuiz @Derasnef @IcyfaSemi

💧 The Chloride Paradigm Shift in Heart Failure From a neglected ion ➜ to a keystone of precision diuretic therapy. 🧠 Hypochloremia drives diuretic resistance, persistent congestion & worse outcomes. 🔄 New therapeutic algorithm integrating Cl⁻ into Mullens' strategy. 🆕 Collaboration🤝 @SENefrologia @secardiologia @IcyfaSemi @ESC_Journals DOI: doi.org/10.1002/ejhf.7…

¿Qué tienes que conocer de lo presentado en el Congreso de la ERA? #TakeHomeMessages ▶️SAVE THE DATE! 25 junio, 17h CEST Webinar: Lo + destacado de la ERA de la mano de 5 nefrólogos expertos en distintas áreas @senjoven @JaimeMazonRuiz | Moderación de @ClaraGCarro y @annabuxeda Inscripción gratuita→ senefro.org/modules.php?na… Gracias a @GSK @NovoNordiskES

And yet the most frequent etiological diagnosis of CKD... 🙈🙈 "imprecision medicine"

Cuestión de egos: Dos guías europeas sobre HTA publicadas en agosto 2024. Distintas clasificaciones. ¿Es tan difícil ponerse de acuerdo? - sciencedirect.com/science/articl… - academic.oup.com/eurheartj/adva… - @SENefrologia @SOMANEorg - #Nefro_8_01

💥¿Preeclampsia 🤰?💥 🩹KEEP CALM & show me Órgano Diana🎯 🟢 Generalizar objetivos menos laxos de PA 🙏 🟢 👇Monitorizar 🔎🐥 🔴 Cuándo Finalizar Gestación⚠️ 🔴 HELLP=MAT🧐 🟡 Tratamiento antiHTA VO/EV 🤔🟡 🤓 @jlperezcanga C. Sanchez Blanco 👉👉 #gallery-2-18" target="_blank" rel="nofollow noopener">nefrologiaaldia.org/es-articulo-ma…

It’s time to dive deep into the world of fluid tolerance/responsiveness 💦 @NephroP and @Tubulocentric have some insights to share👁️ Integrating PoCUS into our clinical practice is crucial.And let's not forget that the heart can also be insonated by nephrologists @JaimeMazonRuiz

#FLOW Semaglutide 1mg OW on kidney outcomes in CKD and T2D #ERA24 Kidney endpoint: HR 0,76 ✅ eGFR slope: -1.16 mL/min/1.73m2/yr ✅ Time to first MACE: HR 0.82 ✅ Time to all cause ☠️: HR 0.80 ✅ @SENefrologia @senjoven

@CKJsocial #ERA24 Stockholm Proud authors🇪🇸💚

Happy to be back on #ERA24 with a #PoCUS workshop with two great experts @NephroP and @NephroNess echonousproduct.com

🙌Over 2200 abstracts submitted to @ERAkidney . 🇪🇸Spain ranking first with the highest number! @RonGansevoort #ERA24 @SENefrologia

PoCUS en lesión renal asociado a cirrosis en @AEcodigest por el Dr @Tubulocentric Interesante charla👈 💡La ecografía aporta información en el paciente cirrotico, más allá del cribado, ascitis o Trombosis ♦️ Importante: evaluar la congestión del paciente cirrótico #AEED2024

@NephroP What an amazing imagination you have! Thanks for sharing!

Friday #POCUS classic: Dinosaur head sign❗️ Subxiphoid view demonstrating, Right pleural effusion = mouth Atelectatic lung = tongue Head = liver Eye = IVC #MedEd #FOAMed #Nephpearls

@ArgaizR @EmiliSanAlv @JaimeMazonRuiz @Tubulocentric Gracias Argaiz, haber podido trabajar en conjunto ha sido un honor gratificante.

Fantastic collaboration with 🇪🇸 #POCUS experts! @Derasnef @EmiliSanAlv @JaimeMazonRuiz @Tubulocentric Acute Kidney Injury and Point-of-Care Ultrasound in Liver Cirrhosis: Redefining Hepatorenal Syndrome academic.oup.com/ckj/article/do…

Acute Kidney Injury and Point-of-Care Ultrasound in Liver Cirrhosis: Redefining Hepatorenal Syndrome academic.oup.com/ckj/article/do… @EmiliSanAlv @JaimeMazonRuiz @ArgaizR @hgermanstrias @nfrgermanstrias @JonathanNefro @Derasnef @SENefrologia @ERAkidney @bover_j @nefrocat

It's time to rethink how we approach hepatorenal syndrome and the role of POCUS in diagnosis and treatment. Thanks to the authors, we've got a new way of looking at a complex condition.@JaimeMazonRuiz @Tubulocentric @EmiliSanAlv @ArgaizR @SENefrologia academic.oup.com/ckj/article/do…